Inventor · disambiguated record
Hongsheng Xie
Also filed as: XIE HONGSHENG
12 granted patents·11 pending applications·28 citations·filing 2013–2023
87Inventor score
Top patents by PatentIndex Score
23 records- 0194US11779663B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2020·Granted Oct 10, 2023·4 cites·10 claims
- 0292US11129910B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2016·Granted Sep 28, 2021·8 cites·33 claims
- 0389US10836796B2Derivatives of amanita toxins and their conjugation to a cell binding moleculeHANGZHOU DAC BIOTECH CO LTD·Filed 2016·Granted Nov 17, 2020·11 cites·27 claims
- 0486US12220464B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted Feb 11, 2025·1 cites·21 claims
- 0577US12285491B2Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2022·Granted Apr 29, 2025·0 cites·11 claims
- 0674US12303571B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted May 20, 2025·0 cites·13 claims
- 0774US10646585B2Hydrophilic linkers and ligand-drug conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2018·Granted May 12, 2020·1 cites·14 claims
- 0874US2023165931A1A conjugate of a tubulysin analog with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0974US2023149502A1Conjugate of a tubulysin analog with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1074US2023165930A1Conjugate of a tubulysin analog with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 1173US12478695B2Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Granted Nov 25, 2025·0 cites·20 claims
- 1270US9603908B2Subcutaneous administration of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Mar 28, 2017·2 cites·24 claims
- 1369US10456479B2Hydrophilic linkers and ligand-drug conjugates thereofHANGZHOU DAC BIOTECH CO LTD·Filed 2015·Granted Oct 29, 2019·1 cites·26 claims
- 1468US2023001001A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1568US2021393790A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1668US2021369855A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2021·Application pending·0 cites
- 1763US12364767B2Conjugation linkers, cell binding molecule-drug conjugates containing the linkers, methods of making and uses such conjugates with the linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2016·Granted Jul 22, 2025·0 cites·34 claims
- 1857US2020069814A1Conjugation of a cytotoxic drug with bis-linkageHANGZHOU DAC BIOTECH CO LTD·Filed 2017·Application pending·0 cites
- 1955US11998584B2Conjugate of a tubulysin analog with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2017·Granted Jun 4, 2024·0 cites·20 claims
- 2049US2023115871A1A conjugate of a cytotoxic agent to a cell binding molecule with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 2146US2023010108A1A conjugation linker containing 2,3-diaminosuccinyl groupHANGZHOU DAC BIOTECH CO LTD·Filed 2018·Application pending·0 cites
- 2245US2021169896A1A cross-linked pyrrolobenzodiazepine dimer (pbd) derivative and its conjugatesHANGZHOU DAC BIOTECH CO LTD·Filed 2018·Application pending·0 cites
- 2341US2023057350A1A conjugate of an amanita toxin with branched linkersHANGZHOU DAC BIOTECH CO LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →